|
|
|
Pharming Group N v (NASDAQ: PHAR) |
|
Pharming Group N v
PHAR's Fundamental analysis
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
|
Looking into Pharming Group N V growth rates, revenue grew
by 19.2 % in IV. Quarter 2023 from the same quarter a year ago.
Ranking at No. 2000
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -4.85 %
Pharming Group N V faced net loss in contrast to the net income a year ago in IV. Quarter 2023
• More on PHAR's Growth
|
|
Pharming Group N V
realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 25.94 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Company's Price to Sales ratio is at 21.95.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.
• More on PHAR's Valuation
|
|
|
|
|
Pharming Group N V
realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 25.94 in trailing twelve-month period. |
| Company |
| - |
|
PE TTM
|
| Industry |
|
- |
|
PE TTM
|
|
Company's Price to Sales ratio is at 21.95.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.
Pharming Group N V Price to Book Ratio is at 24.59 lower than Industry Avg. of 77.28. and higher than S&P 500 Avg. of 0.01
• More on PHAR's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
